HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

THC

Tenet Healthcare Corporation (NYSE)

Healthcare — Medical Care Facilities

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

Strong Buy 1.5 / 5 21 analysts
$193.26
+$2.06 (+1.08%)
Target: $243.19 (25.8%)
Sign in to add THC to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$16.65B
P/E Ratio (TTM)10.05
Forward P/E10.91
EPS (TTM)$19.23
Dividend Yield-
Profit Margin7.94%
Revenue Growth2.80%
ROE30.29%
Debt/Equity149.25
Recommendation Strong Buy 1.5
Analyst Target$243.19
Analysts21
Indexes NYSE

Technical Indicators

RSI (14)71.9
Beta1.28
SMA 20-
SMA 40-
52-Week High$247.21
52-Week Low$146.60
50-Day Avg$181.34
200-Day Avg$198.48
Avg Volume$1.47M
Volume10.2K

Performance Analysis

BULLISH

THC shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 46% of its 52-week range.
- RSI at 71.9 indicates overbought conditions — a pullback may be due.
+ P/E of 10.0 suggests the stock may be undervalued.
~ Modest revenue growth of 2.8% year-over-year.
+ Wall Street consensus is "Strong Buy" from 21 analysts.
+ Average analyst target of $243.19 implies 25.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:34 UTC

Back to Screener Export Report